Examkin

Soru

Zorluk: ZorPreventive Care and Screening

During a scheduled annual health review, a 46-year-old female patient voices deep concerns about her familial cancer risk. She notes that her mother received a diagnosis of epithelial ovarian cancer one month ago at the age of 68. Furthermore, her maternal aunt was treated for breast cancer diagnosed at age 52. Her medical background includes uncomplicated essential hypertension managed with lisinopril. Preventive care records demonstrate a negative screening colonoscopy performed 14 months ago, a negative digital mammogram completed 3 months ago, and a normal cervical cytology with negative high-risk human papillomavirus (HPV) co-testing conducted 2 years prior. Today's physical assessment, including a comprehensive clinical breast examination, reveals no abnormalities. Vital signs are within normal limits. Based on current evidence-based guidelines, which of the following is the most appropriate next step in the management of this patient?

  1. Provide a referral for familial cancer susceptibility genetic counselingCevap
  2. B
    Order a transvaginal ultrasound and serum cancer antigen 125 (CA-125) level
  3. C
    Schedule an immediate screening magnetic resonance imaging (MRI) scan of the breasts
  4. D
    Repeat cervical cytology with human papillomavirus (HPV) co-testing today
  5. E
    Reassure the patient that specialized assessment is unnecessary because her mother's diagnosis occurred after age 65

Cevap

Provide a referral for familial cancer susceptibility genetic counseling
The correct action is to provide a referral for genetic counseling. According to the United States Preventive Services Task Force (USPSTF), primary care providers should evaluate women with a family history of breast, ovarian, tubal, or peritoneal cancer to identify those at risk for potentially harmful BRCA1 or BRCA2 mutations. Because this patient has a first-degree relative with ovarian cancer, she is considered high-risk. The evidence-based next step is formal genetic counseling, which must occur before genetic testing or transitioning to high-risk screening modalities.

Adım Adım Çözüm

1
Analyze the patient's family history for high-risk cancer patterns.
The patient has a first-degree relative (mother) with ovarian cancer and a second-degree relative (aunt) with breast cancer.
Identifying specific familial patterns is necessary to determine if standard risk-based screening guidelines apply or if the patient requires high-risk management.
2
Evaluate the current USPSTF guidelines regarding BRCA-related cancer screening.
A first-degree relative with ovarian cancer at any age meets the criteria for a positive familial risk assessment.
Guidelines mandate that primary care providers identify women with a family history of breast, ovarian, tubal, or peritoneal cancer.
3
Determine the appropriate sequential intervention for a positive familial risk assessment.
The indicated intervention is a referral for formal genetic counseling, rather than immediately ordering advanced imaging or tumor markers.
Genetic counseling ensures the patient understands the implications of genetic testing before proceeding to specialized surveillance (like MRI) or prophylactic measures.

Anahtar Kavram

Women with a strong family history of BRCA-associated cancers (such as a first-degree relative with ovarian cancer at any age) should be referred for genetic counseling before any alterations are made to their imaging or laboratory screening protocols.
Tahmini Süre:1m 30s
Bu soruyu puanla

Konular

Preventive Care and Screening

Bu konudan daha fazla soru